Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Long-Term Investments (2016 - 2017)

Historic Long-Term Investments for AC Immune (ACIU) over the last 4 years, with Q4 2017 value amounting to $127711.0.

  • AC Immune's Long-Term Investments rose 4849.75% to $127711.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $127711.0, marking a year-over-year increase of 4849.75%. This contributed to the annual value of $127711.0 for FY2017, which is 4849.75% up from last year.
  • As of Q4 2017, AC Immune's Long-Term Investments stood at $127711.0, which was up 4849.75% from $125491.4 recorded in Q1 2017.
  • AC Immune's 5-year Long-Term Investments high stood at $127711.0 for Q4 2017, and its period low was $85895.2 during Q4 2015.
  • Its 4-year average for Long-Term Investments is $100071.8, with a median of $87665.5 in 2016.
  • As far as peak fluctuations go, AC Immune's Long-Term Investments crashed by 260.84% in 2015, and later surged by 4849.75% in 2017.
  • AC Immune's Long-Term Investments (Quarter) stood at $88195.7 in 2014, then fell by 2.61% to $85895.2 in 2015, then increased by 0.12% to $86002.1 in 2016, then surged by 48.5% to $127711.0 in 2017.
  • Its Long-Term Investments stands at $127711.0 for Q4 2017, versus $125491.4 for Q1 2017 and $86002.1 for Q4 2016.